SnapDNA on Republic | Should You Invest?

SnapDNA on Republic | Should You Invest?

Company Overview

The company developed a rapid, on-site analysis for foodborne pathogens such as Listeria, E. coli and Salmonella for use by food processors. The system is designed to replace currently used diagnostic tools that take 3-7 days to analyze food contaminations. According to the company, the system is also capable of providing quantitative RNA/DNA analysis and has third party validation from industry and the USDA, as well as pilots with the world's largest food companies (including PepsiCo).

Invest in SnapDNA
Republic is a startup investing platform where you can invest as little as $10 in impactful startups

SnapDNA Business Structure

  • Form: Corporation
  • Jurisdiction of Incorporation/Organization: Delaware
  • Date of organization: April 19, 2011

The Deal Terms

  • Security: Crowd SAFE
  • Valuation Cap: $28,000,000
  • Discount Rate: 10%
  • Min. Offering Amount: $25,000
  • Max. Offering Amount: $1,070,000
  • Min. Investment: $150
Will I Invest in SnapDNA? Subscribe to the Angel Notes Newsletter to find out!

Competition

According to the company, there have been numerous attempts at rapid pathogen detection in an hour or less for the food processing industry but none before SnapDNA have addressed all of the specific, non-negotiable industry requirements to replace lab tests (detect only live cells, work with industry accepted sample size and collection methods, and provide near-zero false positive results).

While there have been other companies that have targeted pathogen detection the food industry, none have met the requirements for broad adoption by the industry. Neogen and Clear Labs are players in the category.

Source: SnapDNA Form C.

Intellectual Property

The company has submitted an additional 2020 patent application and currently holds the following patents:

Snap DNA's Intellectual Property
Source

How will SnapDNA Use The Funds Raised On Republic?

SnapDNA Use Of Republic Campaign's Funds
Source

The Team

David Medin (CEO) has 30 years executive and C-level experience in semi-conductor design and development. He's opened opportunities in emerging multi-billion-dollar businesses and has led large global product development teams.

Thomas Jacobs (VP Sales) has 25 years of sales leadership at food processers including 12 years at Tyson Foods.

Employees: The company currently employs 3 employees.

The Financials

Oracle Health's Financials
Source
Will I Invest in SnapDNA? Subscribe to the Angel Notes Newsletter to find out!
Great! Next, complete checkout for full access to Angel Notes.
Welcome back! You've successfully signed in.
You've successfully subscribed to Angel Notes.
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info has been updated.
Your billing was not updated.